CDC staff presented data showing that hospitalization rates for Covid are highest for adults 75 and older, followed by babies ...
The Advisory Committee on Immunization Practices recommended that only people 65 and older and those with an underlying ...
On Friday, a CDC advisory panel unanimously recommended limiting the Covid shot to people 65 and older or those with ...
The CDC advisory committee met to discuss the science surrounding Covid-19 vaccines, nearly approving a controversial ...
Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.
Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and ...
After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...
Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...
In the latest trading session, Moderna (MRNA) closed at $25.51, marking a +2.03% move from the previous day. This change outpaced the S&P 500's 0.48% gain on the day. On the other hand, the Dow ...
Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...
Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which ...